The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
NA ID: ALA4878281
PubChem CID: 164628751
Max Phase: Preclinical
Molecular Formula: C28H29ClN4O4
Molecular Weight: 484.56
Molecule Type: Unknown
Associated Items:
Names and Identifiers Canonical SMILES: Cl.O=C(N[C@@H]1C=C[C@@]2(O)[C@H]3Cc4ccc(O)c5c4[C@@]2(CCN3CC2CC2)[C@H]1O5)c1n[nH]c2ccccc12
Standard InChI: InChI=1S/C28H28N4O4.ClH/c33-20-8-7-16-13-21-28(35)10-9-19(29-26(34)23-17-3-1-2-4-18(17)30-31-23)25-27(28,22(16)24(20)36-25)11-12-32(21)14-15-5-6-15;/h1-4,7-10,15,19,21,25,33,35H,5-6,11-14H2,(H,29,34)(H,30,31);1H/t19-,21-,25+,27+,28-;/m1./s1
Standard InChI Key: GSSMUVMDVOHBMO-QTJUMRCSSA-N
Molfile:
RDKit 2D
39 45 0 0 0 0 0 0 0 0999 V2000
7.6607 -23.2179 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
6.0830 -20.5724 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.2638 -20.5724 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.4989 -19.8624 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.8647 -21.2739 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.4863 -21.2739 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.6377 -21.7612 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
6.0621 -19.1524 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.8647 -19.8624 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.3182 -19.8624 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.2638 -19.1524 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.0830 -18.3290 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
5.6630 -19.8582 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.7298 -20.5766 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.3098 -21.2866 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.0414 -21.2739 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.6630 -18.8500 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.0414 -19.8624 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.6254 -20.5724 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.6170 -21.9966 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
7.7172 -22.0049 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
6.4948 -17.6023 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.4821 -22.1940 0.0000 H 0 0 0 0 0 0 0 0 0 0 0 0
6.9107 -19.1399 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
6.7721 -18.7408 0.0000 H 0 0 0 0 0 0 0 0 0 0 0 0
8.5491 -22.0113 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.9594 -22.7347 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.9704 -21.2941 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
7.3266 -17.5955 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.0471 -18.0017 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.0403 -17.1699 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.6198 -23.4905 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
9.2337 -24.0517 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
9.7904 -22.8264 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.9532 -23.6381 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.7359 -23.9013 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.3566 -23.3541 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.1893 -22.5402 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.4067 -22.2806 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3 2 1 0
4 2 1 0
5 3 2 0
6 2 1 0
7 6 1 0
8 4 1 0
9 3 1 0
10 4 1 0
11 8 1 0
12 17 1 0
2 13 1 1
14 15 1 0
15 6 1 0
16 5 1 0
17 13 1 0
18 9 2 0
19 18 1 0
20 16 1 0
15 21 1 1
22 12 1 0
6 23 1 1
4 24 1 1
8 25 1 6
7 5 1 0
12 8 1 0
14 10 2 0
11 9 1 0
16 19 2 0
21 26 1 0
26 27 1 0
26 28 2 0
22 29 1 0
30 29 1 0
31 30 1 0
29 31 1 0
27 32 2 0
32 33 1 0
33 35 1 0
34 27 1 0
34 35 2 0
35 36 1 0
36 37 2 0
37 38 1 0
38 39 2 0
39 34 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 484.56Molecular Weight (Monoisotopic): 484.2111AlogP: 2.41#Rotatable Bonds: 4Polar Surface Area: 110.71Molecular Species: BASEHBA: 6HBD: 4#RO5 Violations: ┄HBA (Lipinski): 8HBD (Lipinski): 4#RO5 Violations (Lipinski): ┄CX Acidic pKa: 9.88CX Basic pKa: 9.35CX LogP: 1.75CX LogD: 0.34Aromatic Rings: 3Heavy Atoms: 36QED Weighted: 0.42Np Likeness Score: 0.56
References 1. Ma H, Wang H, Gillespie JC, Mendez RE, Selley DE, Zhang Y.. (2021) Exploring naltrexamine derivatives featuring azaindole moiety via nitrogen-walk approach to investigate their in vitro pharmacological profiles at the mu opioid receptor., 41 [PMID:33766769 ] [10.1016/j.bmcl.2021.127953 ]